pyridine sulfonamide

structure in first source

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 01/01/2014 - "Indeed, ts-SA is a promiscuous, low nanomolar inhibitor of 7 out of 10 human (h) CA isoforms, whereas the pyridine sulfonamide is a low nanomolar inhibitor only of the tumor-associated hCA IX and XII, being less effective against other 9 isoforms. "
2.	Diabetes Mellitus 12/01/2015 - "Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase."
3.	Alzheimer Disease (Alzheimer's Disease) 12/01/2015 - "Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase."
4.	Colorectal Neoplasms (Colorectal Cancer) 01/01/2023 - "Herein we adopted this approach in the design and synthesis of a series of novel pyridine sulfonamide-pyrazole hybrid scaffold mimicking dual-tail inhibitors of CA IX. A library of 15 compounds was synthesized and assessed for their potential cytotoxic effects against colorectal cancer cells. "